Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-145
Closed -$3K 1030
2022
Q3
$3K Hold
145
﹤0.01% 981
2022
Q2
$3K Hold
145
﹤0.01% 1010
2022
Q1
$5K Sell
145
-1
-0.7% -$36 ﹤0.01% 983
2021
Q4
$6K Hold
146
﹤0.01% 964
2021
Q3
$6K Hold
146
﹤0.01% 973
2021
Q2
$7K Hold
146
﹤0.01% 917
2021
Q1
$6K Hold
146
﹤0.01% 974
2020
Q4
$6K Hold
146
﹤0.01% 951
2020
Q3
$6K Buy
+146
New +$5.59K ﹤0.01% 893
2020
Q1
Sell
-92
Closed -$3K 993
2019
Q4
$3K Hold
92
﹤0.01% 876
2019
Q3
$3K Hold
92
﹤0.01% 916
2019
Q2
$3K Hold
92
﹤0.01% 901
2019
Q1
$3K Hold
92
﹤0.01% 858
2018
Q4
$3K Hold
92
﹤0.01% 836
2018
Q3
$3K Hold
92
﹤0.01% 914
2018
Q2
$4K Hold
92
﹤0.01% 858
2018
Q1
$3K Sell
92
-1
-1% -$30 ﹤0.01% 929
2017
Q4
$3K Buy
+93
New +$2.82K ﹤0.01% 973

Other funds holding NEOG

Smithfield Trust's NEOG Position: Q4 2022 in Review

Smithfield Trust sold out of Neogen (NEOG) in Q4 2022, closing a stake of 145 shares — an estimated $3K sold.

Smithfield Trust first reported a position in NEOG in Q4 2017 and held it in 18 quarters. The position peaked at $7K in Q2 2021. 369 funds tracked by Wall St. Rank hold NEOG as of Q4 2022.

  • Smithfield Trust reported no remaining Neogen position as of Q4 2022 after selling out during the quarter.
  • Smithfield Trust sold 145 Neogen shares in Q4 2022, an estimated $3K.
  • Smithfield Trust first reported a position in Neogen in Q4 2017 and held it in 18 quarters.
  • Smithfield Trust's Neogen position peaked at $7K in Q2 2021.
  • 369 funds tracked by Wall St. Rank held Neogen as of Q4 2022.

Based on Smithfield Trust's 13F filing for Q4 2022, filed 13 Feb 2023.